Children of depressed mothers 1 year after the initiation of maternal treatment: Findings from the STAR*D-child study

Daniel J. Pilowsky, Priya Wickramaratne, Ardesheer Talati, Min Tang, Carroll W. Hughes, Judy Garber, Erin Malloy, Cheryl King, Gabrielle Cerda, A. Bela Sood, Jonathan E. Alpert, Madhukar H. Trivedi, Maurizio Fava, A. John Rush, Stephen Wisniewski, Myrna M. Weissman

Research output: Contribution to journalArticle

136 Citations (Scopus)

Abstract

Objective: Maternal depression is a consistent and well-replicated risk factor for child psychopathology. The authors examined the changes in psychiatric symptoms and global functioning in children of depressed women 1 year following the initiation of treatment for maternal major depressive disorder. Method: Participants were 1) 151 women with maternal major depression who were enrolled in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study and 2) their eligible offspring who, along with the mother, participated in the child STAR*D (STAR*D-Child) study (mother-child pairs: N=151). The STAR*D study was a multisite study designed to determine the comparative effectiveness and acceptability of various treatment options for adult outpatients with nonpsychotic major depressive disorder. The STAR*D-Child study examined children of depressed women at baseline and involved periodic follow-ups for 1 year after the initiation of treatment for maternal major depressive disorder to ascertain the following data: 1) whether changes in children's psychiatric symptoms were associated with changes in the severity of maternal depression and 2) whether outcomes differed among the offspring of women who did and did not remit (mother-child pairs with follow-up data: N=123). Children's psychiatric symptoms in the STAR*D-Child study were assessed using the Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL), and maternal depression severity in the STAR*D study was assessed by an independent clinician, using the 17-item Hamilton Depression Rating Scale (HAM-D). Results: During the year following the initiation of treatment, maternal depression severity and children's psychiatric symptoms continued to decrease over time. Decreases in the number of children's psychiatric symptoms were significantly associated with decreases in maternal depression severity. When children's outcomes were examined separately, a statistically significant decrease in symptoms was evident in the offspring of women who remitted early (i.e., within the first 3 months after the initiation of treatment for maternal depression) or late (i.e., over the 1-year follow-up interval) but not in the offspring of nonremitting women. Conclusions: Continued efforts to treat maternal depression until remission is achieved are associated with decreased psychiatric symptoms and improved functioning in the offspring.

Original languageEnglish (US)
Pages (from-to)1136-1147
Number of pages12
JournalAmerican Journal of Psychiatry
Volume165
Issue number9
DOIs
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

Mothers
Depression
Child Psychiatry
Therapeutics
Major Depressive Disorder
Psychiatry
Psychopathology
Mood Disorders
Schizophrenia
Appointments and Schedules
Outpatients

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Pilowsky, D. J., Wickramaratne, P., Talati, A., Tang, M., Hughes, C. W., Garber, J., ... Weissman, M. M. (2008). Children of depressed mothers 1 year after the initiation of maternal treatment: Findings from the STAR*D-child study. American Journal of Psychiatry, 165(9), 1136-1147. https://doi.org/10.1176/appi.ajp.2008.07081286

Children of depressed mothers 1 year after the initiation of maternal treatment : Findings from the STAR*D-child study. / Pilowsky, Daniel J.; Wickramaratne, Priya; Talati, Ardesheer; Tang, Min; Hughes, Carroll W.; Garber, Judy; Malloy, Erin; King, Cheryl; Cerda, Gabrielle; Sood, A. Bela; Alpert, Jonathan E.; Trivedi, Madhukar H.; Fava, Maurizio; Rush, A. John; Wisniewski, Stephen; Weissman, Myrna M.

In: American Journal of Psychiatry, Vol. 165, No. 9, 09.2008, p. 1136-1147.

Research output: Contribution to journalArticle

Pilowsky, DJ, Wickramaratne, P, Talati, A, Tang, M, Hughes, CW, Garber, J, Malloy, E, King, C, Cerda, G, Sood, AB, Alpert, JE, Trivedi, MH, Fava, M, Rush, AJ, Wisniewski, S & Weissman, MM 2008, 'Children of depressed mothers 1 year after the initiation of maternal treatment: Findings from the STAR*D-child study', American Journal of Psychiatry, vol. 165, no. 9, pp. 1136-1147. https://doi.org/10.1176/appi.ajp.2008.07081286
Pilowsky, Daniel J. ; Wickramaratne, Priya ; Talati, Ardesheer ; Tang, Min ; Hughes, Carroll W. ; Garber, Judy ; Malloy, Erin ; King, Cheryl ; Cerda, Gabrielle ; Sood, A. Bela ; Alpert, Jonathan E. ; Trivedi, Madhukar H. ; Fava, Maurizio ; Rush, A. John ; Wisniewski, Stephen ; Weissman, Myrna M. / Children of depressed mothers 1 year after the initiation of maternal treatment : Findings from the STAR*D-child study. In: American Journal of Psychiatry. 2008 ; Vol. 165, No. 9. pp. 1136-1147.
@article{5b23bb04659a4f20a3d09218f83aa47f,
title = "Children of depressed mothers 1 year after the initiation of maternal treatment: Findings from the STAR*D-child study",
abstract = "Objective: Maternal depression is a consistent and well-replicated risk factor for child psychopathology. The authors examined the changes in psychiatric symptoms and global functioning in children of depressed women 1 year following the initiation of treatment for maternal major depressive disorder. Method: Participants were 1) 151 women with maternal major depression who were enrolled in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study and 2) their eligible offspring who, along with the mother, participated in the child STAR*D (STAR*D-Child) study (mother-child pairs: N=151). The STAR*D study was a multisite study designed to determine the comparative effectiveness and acceptability of various treatment options for adult outpatients with nonpsychotic major depressive disorder. The STAR*D-Child study examined children of depressed women at baseline and involved periodic follow-ups for 1 year after the initiation of treatment for maternal major depressive disorder to ascertain the following data: 1) whether changes in children's psychiatric symptoms were associated with changes in the severity of maternal depression and 2) whether outcomes differed among the offspring of women who did and did not remit (mother-child pairs with follow-up data: N=123). Children's psychiatric symptoms in the STAR*D-Child study were assessed using the Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL), and maternal depression severity in the STAR*D study was assessed by an independent clinician, using the 17-item Hamilton Depression Rating Scale (HAM-D). Results: During the year following the initiation of treatment, maternal depression severity and children's psychiatric symptoms continued to decrease over time. Decreases in the number of children's psychiatric symptoms were significantly associated with decreases in maternal depression severity. When children's outcomes were examined separately, a statistically significant decrease in symptoms was evident in the offspring of women who remitted early (i.e., within the first 3 months after the initiation of treatment for maternal depression) or late (i.e., over the 1-year follow-up interval) but not in the offspring of nonremitting women. Conclusions: Continued efforts to treat maternal depression until remission is achieved are associated with decreased psychiatric symptoms and improved functioning in the offspring.",
author = "Pilowsky, {Daniel J.} and Priya Wickramaratne and Ardesheer Talati and Min Tang and Hughes, {Carroll W.} and Judy Garber and Erin Malloy and Cheryl King and Gabrielle Cerda and Sood, {A. Bela} and Alpert, {Jonathan E.} and Trivedi, {Madhukar H.} and Maurizio Fava and Rush, {A. John} and Stephen Wisniewski and Weissman, {Myrna M.}",
year = "2008",
month = "9",
doi = "10.1176/appi.ajp.2008.07081286",
language = "English (US)",
volume = "165",
pages = "1136--1147",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "9",

}

TY - JOUR

T1 - Children of depressed mothers 1 year after the initiation of maternal treatment

T2 - Findings from the STAR*D-child study

AU - Pilowsky, Daniel J.

AU - Wickramaratne, Priya

AU - Talati, Ardesheer

AU - Tang, Min

AU - Hughes, Carroll W.

AU - Garber, Judy

AU - Malloy, Erin

AU - King, Cheryl

AU - Cerda, Gabrielle

AU - Sood, A. Bela

AU - Alpert, Jonathan E.

AU - Trivedi, Madhukar H.

AU - Fava, Maurizio

AU - Rush, A. John

AU - Wisniewski, Stephen

AU - Weissman, Myrna M.

PY - 2008/9

Y1 - 2008/9

N2 - Objective: Maternal depression is a consistent and well-replicated risk factor for child psychopathology. The authors examined the changes in psychiatric symptoms and global functioning in children of depressed women 1 year following the initiation of treatment for maternal major depressive disorder. Method: Participants were 1) 151 women with maternal major depression who were enrolled in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study and 2) their eligible offspring who, along with the mother, participated in the child STAR*D (STAR*D-Child) study (mother-child pairs: N=151). The STAR*D study was a multisite study designed to determine the comparative effectiveness and acceptability of various treatment options for adult outpatients with nonpsychotic major depressive disorder. The STAR*D-Child study examined children of depressed women at baseline and involved periodic follow-ups for 1 year after the initiation of treatment for maternal major depressive disorder to ascertain the following data: 1) whether changes in children's psychiatric symptoms were associated with changes in the severity of maternal depression and 2) whether outcomes differed among the offspring of women who did and did not remit (mother-child pairs with follow-up data: N=123). Children's psychiatric symptoms in the STAR*D-Child study were assessed using the Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL), and maternal depression severity in the STAR*D study was assessed by an independent clinician, using the 17-item Hamilton Depression Rating Scale (HAM-D). Results: During the year following the initiation of treatment, maternal depression severity and children's psychiatric symptoms continued to decrease over time. Decreases in the number of children's psychiatric symptoms were significantly associated with decreases in maternal depression severity. When children's outcomes were examined separately, a statistically significant decrease in symptoms was evident in the offspring of women who remitted early (i.e., within the first 3 months after the initiation of treatment for maternal depression) or late (i.e., over the 1-year follow-up interval) but not in the offspring of nonremitting women. Conclusions: Continued efforts to treat maternal depression until remission is achieved are associated with decreased psychiatric symptoms and improved functioning in the offspring.

AB - Objective: Maternal depression is a consistent and well-replicated risk factor for child psychopathology. The authors examined the changes in psychiatric symptoms and global functioning in children of depressed women 1 year following the initiation of treatment for maternal major depressive disorder. Method: Participants were 1) 151 women with maternal major depression who were enrolled in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study and 2) their eligible offspring who, along with the mother, participated in the child STAR*D (STAR*D-Child) study (mother-child pairs: N=151). The STAR*D study was a multisite study designed to determine the comparative effectiveness and acceptability of various treatment options for adult outpatients with nonpsychotic major depressive disorder. The STAR*D-Child study examined children of depressed women at baseline and involved periodic follow-ups for 1 year after the initiation of treatment for maternal major depressive disorder to ascertain the following data: 1) whether changes in children's psychiatric symptoms were associated with changes in the severity of maternal depression and 2) whether outcomes differed among the offspring of women who did and did not remit (mother-child pairs with follow-up data: N=123). Children's psychiatric symptoms in the STAR*D-Child study were assessed using the Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL), and maternal depression severity in the STAR*D study was assessed by an independent clinician, using the 17-item Hamilton Depression Rating Scale (HAM-D). Results: During the year following the initiation of treatment, maternal depression severity and children's psychiatric symptoms continued to decrease over time. Decreases in the number of children's psychiatric symptoms were significantly associated with decreases in maternal depression severity. When children's outcomes were examined separately, a statistically significant decrease in symptoms was evident in the offspring of women who remitted early (i.e., within the first 3 months after the initiation of treatment for maternal depression) or late (i.e., over the 1-year follow-up interval) but not in the offspring of nonremitting women. Conclusions: Continued efforts to treat maternal depression until remission is achieved are associated with decreased psychiatric symptoms and improved functioning in the offspring.

UR - http://www.scopus.com/inward/record.url?scp=51349128603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51349128603&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.2008.07081286

DO - 10.1176/appi.ajp.2008.07081286

M3 - Article

C2 - 18558646

AN - SCOPUS:51349128603

VL - 165

SP - 1136

EP - 1147

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 9

ER -